Buy Sun Pharmaceutical, target of Rs 1498: Sharekhan
Sharekhan has maintianed its buy rating on Sun Pharmaceutical Industries with a target price of Rs 1498 in its June 04, 2009 research report.
“Sun Pharma’s Q4FY2009 performance was ahead of our expectations primarily due to higher than expected growth in its domestic formulation business and healthy API sales. The non-US business (base business in domestic formulations, ROW formulations and API sales) has been growing at an increasing pace on the back of constant new launches, market penetration and expansion of geographies, thus offsetting the flattish US business in FY2009, indicating momentum in Sun Pharma’s underlying business. On the other hand, USFDA issues pertaining to ruling and incremental acquisition opportunities would act as near-term triggers for the stock. We roll over our valuations to FY2011 earnings estimate and maintain our Buy recommendation on the stock with a revised price target of Rs 1,498 (16x FY2011 earnings),” says Sharekhan’s research report.
Tags: buy or sell Sun Pharmaceutical, call on Sun Pharmaceutical, sharekhan tips, Sun Pharmaceutical
Similar Posts:
Latest Query
- by Sam
Market Stats
Search Our Archives
Research Desk
- Stocks Trading above their 50 day moving average - DMA In Stock Research
- Download free Ebooks based on Technical Analysis In Personal Training
- TOP 100 Stocks with the Highest P/E as on July 14th, 2013 In Stock Research
- TOP 100 Stocks with the Lowest P/E as on July 14th, 2013 In Stock Research
- Charting Pathsala - Your guide to Techincals In Technical Analysis
